Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Systematic Approach to Selecting and Preparing a Medical Power of Attorney in the Gynecologic Oncology Center.

Zhukovsky DS, Soliman PT, Mathew B, Mills S, Bodurka D, Frumovitz M, Meyer LA, Westin S, Nowitz M, Archie L, Fenton S, Lang K, Williams JL, Boving V, Bruera E.

J Oncol Pract. 2019 Oct 15:JOP1900109. doi: 10.1200/JOP.19.00109. [Epub ahead of print]

PMID:
31613720
2.

Impact of compliance with an enhanced recovery after surgery pathway on patient outcomes in open gynecologic surgery.

Iniesta MD, Lasala J, Mena G, Rodriguez-Restrepo A, Salvo G, Pitcher B, Washington LD, Harris M, Meyer LA, Ramirez PT.

Int J Gynecol Cancer. 2019 Oct 9. pii: ijgc-2019-000622. doi: 10.1136/ijgc-2019-000622. [Epub ahead of print]

PMID:
31601647
3.

Disruption of Sema3A/Plexin-A1 inhibitory signalling in oligodendrocytes as a therapeutic strategy to promote remyelination.

Binamé F, Pham-Van LD, Spenlé C, Jolivel V, Birmpili D, Meyer LA, Jacob L, Meyer L, Mensah-Nyagan AG, Po C, Van der Heyden M, Roussel G, Bagnard D.

EMBO Mol Med. 2019 Sep 30:e10378. doi: 10.15252/emmm.201910378. [Epub ahead of print]

4.

Impact of implementation of an enhanced recovery program in gynecologic surgery on healthcare costs.

Harrison RF, Li Y, Guzman A, Pitcher B, Rodriguez-Restrepo A, Cain KE, Iniesta MD, Lasala JD, Ramirez PT, Meyer LA.

Am J Obstet Gynecol. 2019 Jul 31. pii: S0002-9378(19)30946-9. doi: 10.1016/j.ajog.2019.07.039. [Epub ahead of print]

PMID:
31376395
5.

Centers for Medicare and Medicaid Services' Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores and gynecologic oncology surgical outcomes.

Dottino JA, He W, Sun CC, Zhao H, Fu S, Lu KH, Meyer LA.

Gynecol Oncol. 2019 Aug;154(2):405-410. doi: 10.1016/j.ygyno.2019.06.003. Epub 2019 Jun 14.

PMID:
31208738
6.

Outcomes of secondary cytoreductive surgery for patients with platinum-sensitive recurrent ovarian cancer.

Gockley A, Melamed A, Cronin A, Bookman MA, Burger RA, Cristae MC, Griggs JJ, Mantia-Smaldone G, Matulonis UA, Meyer LA, Niland J, O'Malley DM, Wright AA.

Am J Obstet Gynecol. 2019 Jun 14. pii: S0002-9378(19)30773-2. doi: 10.1016/j.ajog.2019.06.009. [Epub ahead of print]

PMID:
31207237
7.

National Patterns of Care and Fertility Outcomes for Reproductive-aged Women with Endometrial Cancer or Atypical Hyperplasia.

Harrison RF, He W, Fu S, Zhao H, Sun CC, Suidan RS, Woodard TL, Rauh-Hain JA, Westin SN, Giordano SH, Meyer LA.

Am J Obstet Gynecol. 2019 May 22. pii: S0002-9378(19)30687-8. doi: 10.1016/j.ajog.2019.05.029. [Epub ahead of print]

PMID:
31128110
8.

Total and out-of-pocket costs of different primary management strategies in ovarian cancer.

Suidan RS, He W, Sun CC, Zhao H, Rauh-Hain JA, Fleming ND, Lu KH, Giordano SH, Meyer LA.

Am J Obstet Gynecol. 2019 Aug;221(2):136.e1-136.e9. doi: 10.1016/j.ajog.2019.04.005. Epub 2019 Apr 6.

PMID:
30965052
9.

Patient characteristics and opioid use prior to discharge after open gynecologic surgery in an enhanced recovery after surgery (ERAS) program.

Hillman RT, Sanchez-Migallon A, Meyer LA, Iniesta MD, Cain KE, Siverand AM, Veum SPL, Suki TS, Lasala JD, Ramirez PT.

Gynecol Oncol. 2019 Jun;153(3):604-609. doi: 10.1016/j.ygyno.2019.03.101. Epub 2019 Mar 20.

PMID:
30902370
10.

Guidelines for perioperative care in gynecologic/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations-2019 update.

Nelson G, Bakkum-Gamez J, Kalogera E, Glaser G, Altman A, Meyer LA, Taylor JS, Iniesta M, Lasala J, Mena G, Scott M, Gillis C, Elias K, Wijk L, Huang J, Nygren J, Ljungqvist O, Ramirez PT, Dowdy SC.

Int J Gynecol Cancer. 2019 Mar 15. pii: ijgc-2019-000356. doi: 10.1136/ijgc-2019-000356. [Epub ahead of print]

PMID:
30877144
11.

Women's preferences for cancer risk management strategies in Lynch syndrome.

Sun CC, Meyer LA, Daniels MS, Bodurka DC, Nebgen DR, Burton-Chase AM, Lu KH, Peterson SK.

Gynecol Oncol. 2019 Mar;152(3):514-521. doi: 10.1016/j.ygyno.2018.11.027.

PMID:
30876497
12.

Comparison of patient reported symptom burden on an enhanced recovery after surgery (ERAS) care pathway in patients with ovarian cancer undergoing primary vs. interval tumor reductive surgery.

Meyer LA, Shi Q, Lasala J, Iniesta MD, Lin HK, Nick AM, Williams L, Sun C, Wang XS, Lu KH, Ramirez PT.

Gynecol Oncol. 2019 Mar;152(3):501-508. doi: 10.1016/j.ygyno.2018.10.044.

PMID:
30876495
13.

Validation and application of a module of the MD Anderson Symptom Inventory for measuring perioperative symptom burden in patients with gynecologic cancer (the MDASI-PeriOp-GYN).

Wang XS, Shi Q, Williams LA, Cleeland CS, Garcia-Gonzalez A, Chen TY, Shahid DR, Ramirez PT, Iniesta MD, Siverand AM, Meyer LA.

Gynecol Oncol. 2019 Mar;152(3):492-500. doi: 10.1016/j.ygyno.2018.11.004.

PMID:
30876494
14.

How we use hospice: Hospice enrollment patterns and costs in elderly ovarian cancer patients.

Taylor JS, Zhang N, Rajan SS, Chavez-MacGregor M, Zhao H, Niu J, Meyer LA, Ramondetta LM, Bodurka DC, Lairson DR, Giordano SH.

Gynecol Oncol. 2019 Mar;152(3):452-458. doi: 10.1016/j.ygyno.2018.10.041.

PMID:
30876488
15.

National trends, outcomes, and costs of radiation therapy in the management of low- and high-intermediate risk endometrial cancer.

Suidan RS, He W, Sun CC, Zhao H, Smith GL, Klopp AH, Fleming ND, Lu KH, Giordano SH, Meyer LA.

Gynecol Oncol. 2019 Mar;152(3):439-444. doi: 10.1016/j.ygyno.2018.11.005.

PMID:
30876486
16.

Choosing Wisely: Decreasing the incidence of perioperative blood transfusions in gynecologic oncology.

Prescott LS, Taylor JS, Enbaya A, Marten CA, Myers KN, Meyer LA, Ramirez PT, Levenback CF, Bodurka DC, Schmeler KM.

Gynecol Oncol. 2019 Jun;153(3):597-603. doi: 10.1016/j.ygyno.2019.03.008. Epub 2019 Mar 11.

PMID:
30872025
17.

Variation in resource utilization associated with the surgical management of ovarian cancer.

Rauh-Hain JA, Hidrue MK, Gaccione P, Melamed A, Meyer LA, Keating NL, Giordano SH, Rice LW, Birrer MJ, Del Carmen MG.

Gynecol Oncol. 2019 Mar;152(3):587-593. doi: 10.1016/j.ygyno.2018.12.013. Epub 2018 Dec 19.

PMID:
30579568
18.

Artificial lighting at night alters aquatic-riparian invertebrate food webs.

Sullivan SMP, Hossler K, Meyer LA.

Ecol Appl. 2019 Jan;29(1):e01821. doi: 10.1002/eap.1821. Epub 2018 Dec 19.

PMID:
30566269
19.

Disparities in treatment and survival among elderly ovarian cancer patients.

Taylor JS, He W, Harrison R, Zhao H, Sun CC, Lu KH, Giordano SH, Meyer LA.

Gynecol Oncol. 2018 Nov;151(2):269-274. doi: 10.1016/j.ygyno.2018.08.041. Epub 2018 Sep 22.

PMID:
30253875
20.

Laparoscopic Surgical Algorithm to Triage the Timing of Tumor Reductive Surgery in Advanced Ovarian Cancer.

Fleming ND, Nick AM, Coleman RL, Westin SN, Ramirez PT, Soliman PT, Fellman B, Meyer LA, Schmeler KM, Lu KH, Sood AK.

Obstet Gynecol. 2018 Sep;132(3):545-554. doi: 10.1097/AOG.0000000000002796.

21.

Effect of an Enhanced Recovery After Surgery Program on Opioid Use and Patient-Reported Outcomes.

Meyer LA, Lasala J, Iniesta MD, Nick AM, Munsell MF, Shi Q, Wang XS, Cain KE, Lu KH, Ramirez PT.

Obstet Gynecol. 2018 Aug;132(2):281-290. doi: 10.1097/AOG.0000000000002735.

22.

Neoadjuvant chemotherapy in elderly women with ovarian cancer: Rates of use and effectiveness.

Meyer LA, He W, Sun CC, Zhao H, Wright AA, Suidan RS, Dottino J, Alejandro Rauh-Hain J, Lu KH, Giordano SH.

Gynecol Oncol. 2018 Sep;150(3):451-459. doi: 10.1016/j.ygyno.2018.06.020. Epub 2018 Jun 29.

PMID:
29961559
23.

Three Lymphadenectomy Strategies in Low-Risk Endometrial Carcinoma: A Cost-Effectiveness Analysis.

Suidan RS, Sun CC, Cantor SB, Mariani A, Soliman PT, Westin SN, Lu KH, Giordano SH, Meyer LA.

Obstet Gynecol. 2018 Jul;132(1):52-58. doi: 10.1097/AOG.0000000000002677.

24.

Prospective assessment of patient-reported outcomes in gynecologic cancer patients before and after pelvic exenteration.

Armbruster SD, Sun CC, Westin SN, Bodurka DC, Ramondetta L, Meyer LA, Soliman PT.

Gynecol Oncol. 2018 Jun;149(3):484-490. doi: 10.1016/j.ygyno.2018.03.054. Epub 2018 Apr 2.

25.

Perirenal Adiposity is Associated With Lower Progression-Free Survival From Ovarian Cancer.

Zhang Y, Coletta AM, Allen PK, Parikh AM, Cox-Mattin M, Meyer LA, Sun CC, Basen-Engquist KM, Lu KH, Klopp AH.

Int J Gynecol Cancer. 2018 Feb;28(2):285-292. doi: 10.1097/IGC.0000000000001165.

26.

Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device.

Pal N, Broaddus RR, Urbauer DL, Balakrishnan N, Milbourne A, Schmeler KM, Meyer LA, Soliman PT, Lu KH, Ramirez PT, Ramondetta L, Bodurka DC, Westin SN.

Obstet Gynecol. 2018 Jan;131(1):109-116. doi: 10.1097/AOG.0000000000002390.

27.

Enhanced recovery after surgery (ERAS®) in gynecologic oncology - Practical considerations for program development.

Nelson G, Dowdy SC, Lasala J, Mena G, Bakkum-Gamez J, Meyer LA, Iniesta MD, Ramirez PT.

Gynecol Oncol. 2017 Dec;147(3):617-620. doi: 10.1016/j.ygyno.2017.09.023. Epub 2017 Sep 23. No abstract available.

28.

Treatment Patterns, Outcomes, and Costs for Bowel Obstruction in Ovarian Cancer.

Suidan RS, He W, Sun CC, Zhao H, Ramondetta LM, Badgwell BD, Bodurka DC, Lu KH, Giordano SH, Meyer LA.

Int J Gynecol Cancer. 2017 Sep;27(7):1350-1359. doi: 10.1097/IGC.0000000000000998.

29.

Challenges to delivery and effectiveness of adjuvant radiation therapy in elderly patients with node-positive vulvar cancer.

Swanick CW, Eifel PJ, Huo J, Meyer LA, Smith GL.

Gynecol Oncol. 2017 Jul;146(1):87-93. doi: 10.1016/j.ygyno.2017.05.004. Epub 2017 May 12.

30.

End-of-Life Racial and Ethnic Disparities Among Patients With Ovarian Cancer.

Taylor JS, Rajan SS, Zhang N, Meyer LA, Ramondetta LM, Bodurka DC, Lairson DR, Giordano SH.

J Clin Oncol. 2017 Jun 1;35(16):1829-1835. doi: 10.1200/JCO.2016.70.2894. Epub 2017 Apr 7.

31.

The "value" of value in gynecologic oncology practice in the United States: Society of Gynecologic Oncology evidence-based review and recommendations.

Cohn DE, Ko E, Meyer LA, Wright JD, Temkin SM, Foote J, Jones NL, Havrilesky LJ.

Gynecol Oncol. 2017 Apr;145(1):185-191. doi: 10.1016/j.ygyno.2017.02.024. Epub 2017 Mar 1. Review. No abstract available.

32.

Impact of body mass index and operative approach on surgical morbidity and costs in women with endometrial carcinoma and hyperplasia.

Suidan RS, He W, Sun CC, Zhao H, Fleming ND, Ramirez PT, Soliman PT, Westin SN, Lu KH, Giordano SH, Meyer LA.

Gynecol Oncol. 2017 Apr;145(1):55-60. doi: 10.1016/j.ygyno.2017.01.025. Epub 2017 Jan 26.

33.

Reply to M.S. Copur et al.

Meyer LA, Wright AA.

J Clin Oncol. 2017 Mar;35(7):803. doi: 10.1200/JCO.2016.71.1978. Epub 2016 Dec 28. No abstract available.

PMID:
28029325
34.

Current drug design to target the Semaphorin/Neuropilin/Plexin complexes.

Meyer LA, Fritz J, Pierdant-Mancera M, Bagnard D.

Cell Adh Migr. 2016 Nov;10(6):700-708. Review.

35.

Analysis of Semaphorin-Induced Growth Cone Collapse and Axon Growth Inhibition.

Meyer LA, Kaselis A, Satkauskas S, Bagnard D.

Methods Mol Biol. 2017;1493:171-183.

PMID:
27787850
36.

Impact of treatment year on survival and adverse effects in patients with cervical cancer and paraortic lymph node metastases treated with definitive extended-field radiation therapy.

Osborne EM, Klopp AH, Jhingran A, Meyer LA, Eifel PJ.

Pract Radiat Oncol. 2017 May - Jun;7(3):e165-e173. doi: 10.1016/j.prro.2016.09.003. Epub 2016 Sep 7.

PMID:
27743802
37.

Colloidal Mechanisms of Gold Nanoparticle Loss in Asymmetric Flow Field-Flow Fractionation.

Jochem AR, Ankah GN, Meyer LA, Elsenberg S, Johann C, Kraus T.

Anal Chem. 2016 Oct 18;88(20):10065-10073. doi: 10.1021/acs.analchem.6b02397. Epub 2016 Oct 7.

PMID:
27673742
38.

Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.

Wright AA, Bohlke K, Armstrong DK, Bookman MA, Cliby WA, Coleman RL, Dizon DS, Kash JJ, Meyer LA, Moore KN, Olawaiye AB, Oldham J, Salani R, Sparacio D, Tew WP, Vergote I, Edelson MI.

Gynecol Oncol. 2016 Oct;143(1):3-15. doi: 10.1016/j.ygyno.2016.05.022. Epub 2016 Aug 8.

39.

Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer.

Meyer LA, Cronin AM, Sun CC, Bixel K, Bookman MA, Cristea MC, Griggs JJ, Levenback CF, Burger RA, Mantia-Smaldone G, Matulonis UA, Niland JC, O'Malley DM, Wright AA.

J Clin Oncol. 2016 Nov 10;34(32):3854-3863. doi: 10.1200/JCO.2016.68.1239.

40.

The DISINFECT Initiative: Decreasing the Incidence of Surgical INFECTions in Gynecologic Oncology.

Taylor JS, Marten CA, Munsell MF, Sun CC, Potts KA, Burzawa JK, Nick AM, Meyer LA, Myers K, Bodurka DC, Aloia TA, Levenback CF, Lairson DR, Schmeler KM.

Ann Surg Oncol. 2017 Feb;24(2):362-368. doi: 10.1245/s10434-016-5517-4. Epub 2016 Aug 29.

41.

Inhibition of PlexA1-mediated brain tumor growth and tumor-associated angiogenesis using a transmembrane domain targeting peptide.

Jacob L, Sawma P, Garnier N, Meyer LA, Fritz J, Hussenet T, Spenlé C, Goetz J, Vermot J, Fernandez A, Baumlin N, Aci-Sèche S, Orend G, Roussel G, Crémel G, Genest M, Hubert P, Bagnard D.

Oncotarget. 2016 Sep 6;7(36):57851-57865. doi: 10.18632/oncotarget.11072.

42.

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.

Wright AA, Bohlke K, Armstrong DK, Bookman MA, Cliby WA, Coleman RL, Dizon DS, Kash JJ, Meyer LA, Moore KN, Olawaiye AB, Oldham J, Salani R, Sparacio D, Tew WP, Vergote I, Edelson MI.

J Clin Oncol. 2016 Oct 1;34(28):3460-73. doi: 10.1200/JCO.2016.68.6907. Epub 2016 Aug 8.

43.

What Is the Real Rate of Surgical Site Infection?

Taylor JS, Marten CA, Potts KA, Cloutier LM, Cain KE, Fenton SL, Tatum TN, James DA, Myers KN, Hubbs CA, Burzawa JK, Vachhani S, Nick AM, Meyer LA, Graviss LS, Ware KM, Park AK, Aloia TA, Bodurka DC, Levenback CF, Schmeler KM.

J Oncol Pract. 2016 Oct;12(10):e878-e883.

44.

Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer.

Esselen KM, Cronin AM, Bixel K, Bookman MA, Burger RA, Cohn DE, Cristea M, Griggs JJ, Levenback CF, Mantia-Smaldone G, Meyer LA, Matulonis UA, Niland JC, Sun C, O'Malley DM, Wright AA.

JAMA Oncol. 2016 Nov 1;2(11):1427-1433. doi: 10.1001/jamaoncol.2016.1842.

45.

A call for new standard of care in perioperative gynecologic oncology practice: Impact of enhanced recovery after surgery (ERAS) programs.

Miralpeix E, Nick AM, Meyer LA, Cata J, Lasala J, Mena GE, Gottumukkala V, Iniesta-Donate M, Salvo G, Ramirez PT.

Gynecol Oncol. 2016 May;141(2):371-378. doi: 10.1016/j.ygyno.2016.02.019. Epub 2016 Mar 9. Review.

46.

Combined exposure to big endothelin-1 and mechanical loading in bovine sternal cores promotes osteogenesis.

Meyer LA, Johnson MG, Cullen DM, Vivanco JF, Blank RD, Ploeg HL, Smith EL.

Bone. 2016 Apr;85:115-22. doi: 10.1016/j.bone.2016.02.001. Epub 2016 Feb 12.

47.

Patterns of Care, Predictors, and Outcomes of Adjuvant Therapy for Early- and Advanced-Stage Uterine Clear Cell Carcinoma: A Population-Based Analysis.

Gockley AA, Rauh-Hain JA, Anders AM, Meyer LA, Clemmer J, Lu KH, Clark RM, Schorge JO, del Carmen MG.

Int J Gynecol Cancer. 2016 May;26(4):697-704. doi: 10.1097/IGC.0000000000000661.

PMID:
26825834
48.

Guidelines for postoperative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations--Part II.

Nelson G, Altman AD, Nick A, Meyer LA, Ramirez PT, Achtari C, Antrobus J, Huang J, Scott M, Wijk L, Acheson N, Ljungqvist O, Dowdy SC.

Gynecol Oncol. 2016 Feb;140(2):323-32. doi: 10.1016/j.ygyno.2015.12.019. Epub 2016 Jan 3. No abstract available.

49.

Guidelines for pre- and intra-operative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations--Part I.

Nelson G, Altman AD, Nick A, Meyer LA, Ramirez PT, Achtari C, Antrobus J, Huang J, Scott M, Wijk L, Acheson N, Ljungqvist O, Dowdy SC.

Gynecol Oncol. 2016 Feb;140(2):313-22. doi: 10.1016/j.ygyno.2015.11.015. Epub 2015 Nov 18. No abstract available.

50.

Management for Elderly Women With Advanced-Stage, High-Grade Endometrial Cancer.

Rauh-Hain JA, Pepin KJ, Meyer LA, Clemmer JT, Lu KH, Rice LW, Uppal S, Schorge JO, Del Carmen MG.

Obstet Gynecol. 2015 Dec;126(6):1198-206. doi: 10.1097/AOG.0000000000001140.

PMID:
26551187

Supplemental Content

Loading ...
Support Center